Science
David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition
The longevity researcher will conduct human trials of an oral "reprogramming" drug as part of a $101 million competition. The approach aims to reverse cellular aging through epigenetic reprogramming, though significant scientific challenges remain.
Read full story at MIT Technology Review →V: · A: · D:
Related
Science
Chinese supercomputer leapfrogs best US machines to be ranked world's fastest
China's LineShine supercomputer in Shenzhen has debuted at the top of the Top500 rankings, displacing the US machine El ...
Science
How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery
Immunologist Derya Unutmaz used GPT-5 Pro to work through a longstanding puzzle in T cell behavior, arriving at insights...
Science
From pixels to planning: Earth AI for nature restoration
Google Research describes work applying AI to satellite and aerial imagery for ecological restoration planning, aiming t...